Your browser doesn't support javascript.
loading
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
Schennach, Rebecca; Riedel, Michael; Spellmann, Ilja; Musil, Richard; Obermeier, Michael; Jäger, Markus; Bottlender, Roland; Schmauss, Max; Laux, Gerd; Möller, Hans-Jürgen.
Afiliação
  • Schennach R; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Riedel M; Schoen Clinic Roseneck, Prien am Chiemsee, Germany.
  • Spellmann I; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Musil R; Psychiatric Clinic Rodewisch, Rodewisch, Germany.
  • Obermeier M; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Jäger M; Psychiatric Clinic, Stuttgart, Germany.
  • Bottlender R; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Schmauss M; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Laux G; Department of Psychiatry, Ludwig-Maximilians-University, Munich, Germany.
  • Möller HJ; Psychiatric Clinic, District Hospital Kempten, Kempten, Germany.
Pharmacopsychiatry ; 52(4): 180-185, 2019 Jul.
Article em En | MEDLINE | ID: mdl-30235496
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Esquizofrenia / Tiazóis / Antipsicóticos / Haloperidol Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piperazinas / Esquizofrenia / Tiazóis / Antipsicóticos / Haloperidol Idioma: En Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Alemanha